Surveyor Capital portfolio
45 tracked investments, 7 on the map, $4B raised across the mapped portfolio.
Surveyor Capital45 investments · 7 on the map · $4B raised- Ocular Therapeutix
- Janux Therapeutics
- Zentalis
- Compass PathwaysPost-IPO Equity
- Artiva BiotherapeuticsSeries B
- AllakosPost-IPO Equity
- Plexium
Also in the portfolio
- Oruka Therapeutics
- Triana Biomedicines
- enGene
- VeraDermics
- Forge Biologics
- Soley Therapeutics
- Avenzo Therapeutics
- Rapport Therapeutics
- Design Therapeutics
- Arbor Biotechnologies
- BBOT
- AmbAgon Therapeutics
- Boundless Bio
- Enliven Therapeutics
- ProfoundBio
- Neuron23
- Marea Therapeutics
- Affinivax
- Attralus
- Vanqua Bio
- Mariana Oncology
- Arvinas
- Allogene Therapeutics
- VistaGen
- Lyra Therapeutics
- DTx Pharma
- ImmPACT Bio
- Cullinan Therapeutics
- Ikena Oncology
- Point Biopharma
- Akouos
- VYNE Therapeutics
- Chinook Therapeutics
- Viracta Therapeutics
- Pieris Pharmaceuticals
Investors similar to Surveyor Capital
Logos Capital43 investments · 6 on the map · $3.6B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised
TCG Crossover27 investments · 9 on the map · $4.1B raised
Perceptive Advisors109 investments · 13 on the map · $4.4B raised
EcoR1 Capital41 investments · 10 on the map · $6B raised
Venrock Healthcare Capital Partners34 investments · 6 on the map · $2.1B raised